These results indicate that treatment of HFD-fed mice with a selective RARα agonist, AM80, results in more pronounced hyperglycemia and glucose intolerance as compared to the chow, HFD, and the HFD+AC261066 treated mice. Here, RARA is linked to Hyperglycemia.